Analyst Ratings for Valeant Pharmaceuticals (VRX) [Buys]
VRX Rating Summary
VRX Price Target Summary
- Highest: $80.00 (Deutsche Bank)
- Lowest: $48.00 (Wells Fargo)
- Average: $62.83
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$62.83 (-16%)
Avg. $ Target:
$62.83 (-16%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2013 | Ameriprise Financial | New Coverage | Buy (N/A) |
N/A (N/A) |
74.40 | 74.82 | 0.56% | Details |
| 3/31/2011 | TD Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
50.08 | 74.82 | 49.4% | Details |
| 2/14/2011 | Collins Stewart » Updated 5/2/2011 |
New Coverage | Buy (N/A) |
N/A (N/A) |
40.54 | 74.82 | 84.56% | Details |
| 1/7/2011 | Lazard Capital | Upgrade | Buy (N/A) |
N/A (N/A) |
35.55 | 74.82 | 110.46% | Details |
| 11/8/2010 | Ladenburg Thalmann | New Coverage | Buy (N/A) |
N/A (N/A) |
27.15 | 74.82 | 175.58% | Details |
| 10/4/2010 | Deutsche Bank » Updated 4/4/2013 |
New Coverage | Buy (N/A) |
80.00 (N/A) |
25.75 | 74.82 | 190.56% | Details |
